BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25880269)

  • 1. Relationship of diabetes complications severity to healthcare utilization and costs among Medicare Advantage beneficiaries.
    Hazel-Fernandez L; Li Y; Nero D; Moretz C; Slabaugh L; Meah Y; Baltz J; Patel NC; Bouchard JR
    Am J Manag Care; 2015 Jan; 21(1):e62-70. PubMed ID: 25880269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial/ethnic and gender differences in severity of diabetes-related complications, health care resource use, and costs in a Medicare population.
    Hazel-Fernandez L; Li Y; Nero D; Moretz C; Slabaugh L; Meah Y; Baltz J; Costantino M; Patel NC; Bouchard J
    Popul Health Manag; 2015 Apr; 18(2):115-22. PubMed ID: 25290044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting costs with diabetes complications severity index in claims data.
    Chang HY; Weiner JP; Richards TM; Bleich SN; Segal JB
    Am J Manag Care; 2012 Apr; 18(4):213-9. PubMed ID: 22554010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stratifying healthcare costs using the Diabetes Complication Severity Index.
    Wu CX; Tan WS; Toh MP; Heng BH
    J Diabetes Complications; 2012; 26(2):107-12. PubMed ID: 22465400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective database analysis of the impact of prior authorization for type 2 diabetes medications on health care costs in a Medicare Advantage Prescription Drug Plan population.
    Bergeson JG; Worley K; Louder A; Ward M; Graham J
    J Manag Care Pharm; 2013 Jun; 19(5):374-84. PubMed ID: 23697475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease.
    Gandra SR; Lawrence LW; Parasuraman BM; Darin RM; Sherman JJ; Wall JL
    J Manag Care Pharm; 2006 Sep; 12(7):546-54. PubMed ID: 16981800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The burden of diabetes mellitus for medicare beneficiaries.
    Costantino ME; Stacy JN; Song F; Xu Y; Bouchard JR
    Popul Health Manag; 2014 Oct; 17(5):272-8. PubMed ID: 24865764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health care resource utilization and costs during episodes of care for type 2 diabetes mellitus-related comorbidities.
    Candrilli SD; Meyers JL; Boye K; Bae JP
    J Diabetes Complications; 2015; 29(4):529-33. PubMed ID: 25660136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Household members of persons with Alzheimer's disease: health conditions, healthcare resource use, and healthcare costs.
    Suehs BT; Shah SN; Davis CD; Alvir J; Faison WE; Patel NC; van Amerongen D; Bobula J
    J Am Geriatr Soc; 2014 Mar; 62(3):435-41. PubMed ID: 24576203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in prevalence of diabetic complications and associated healthcare costs during a 10-year follow-up period among a nationwide diabetic cohort.
    Chen HL; Hsu WW; Hsiao FY
    J Diabetes Complications; 2015; 29(4):523-8. PubMed ID: 25770886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient and Health Care Factors Associated With Long-term Diabetes Complications Among Adults With and Without Mental Health and Substance Use Disorders.
    Schmidt EM; Barnes J; Chen C; Trafton J; Frayne S; Harris AHS
    JAMA Netw Open; 2019 Sep; 2(9):e1912060. PubMed ID: 31553472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of obesity with healthcare utilization and costs in a Medicare population.
    Suehs BT; Kamble P; Huang J; Hammer M; Bouchard J; Costantino ME; Renda A
    Curr Med Res Opin; 2017 Dec; 33(12):2173-2180. PubMed ID: 28760001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fracture risk and healthcare resource utilization and costs among osteoporosis patients with type 2 diabetes mellitus and without diabetes mellitus in Japan: retrospective analysis of a hospital claims database.
    Sato M; Ye W; Sugihara T; Isaka Y
    BMC Musculoskelet Disord; 2016 Nov; 17(1):489. PubMed ID: 27887655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing pulmonary hypertension-related hospitalization costs among Medicare Advantage or commercially insured patients with pulmonary arterial hypertension: a retrospective database study.
    Burke JP; Hunsche E; Régulier E; Nagao M; Buzinec P; Drake Iii W
    Am J Manag Care; 2015 Jan; 21(3 Suppl):s47-58. PubMed ID: 25734573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with increased healthcare costs in Medicare Advantage patients with type 2 diabetes enrolled in a large representative health insurance plan in the US.
    Slabaugh SL; Curtis BH; Clore G; Fu H; Schuster DP
    J Med Econ; 2015 Feb; 18(2):106-12. PubMed ID: 25333214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological characteristics, medical costs and healthcare resource utilization of diabetes-related complications among Chinese patients with type 2 diabetes mellitus.
    Duan X; Li Y; Liu Q; Liu L; Li C
    Expert Rev Pharmacoecon Outcomes Res; 2020 Oct; 20(5):513-521. PubMed ID: 31456456
    [No Abstract]   [Full Text] [Related]  

  • 17. Direct medical costs for complications among children and adults with diabetes in the US commercial payer setting.
    Yeaw J; Halinan S; Hines D; Delozier A; Perez M; Boye M; Boye KS; Blanchette CM
    Appl Health Econ Health Policy; 2014 Apr; 12(2):219-30. PubMed ID: 24573912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world health plan claims analysis of differences in healthcare utilization and total cost in patients suffering from cluster headaches and those without headache-related conditions.
    Polson M; Lord TC; Evangelatos TM; Lopes M; Santaniello BL
    Am J Manag Care; 2017 Nov; 23(16 Suppl):S295-S299. PubMed ID: 29144719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization.
    Young BA; Lin E; Von Korff M; Simon G; Ciechanowski P; Ludman EJ; Everson-Stewart S; Kinder L; Oliver M; Boyko EJ; Katon WJ
    Am J Manag Care; 2008 Jan; 14(1):15-23. PubMed ID: 18197741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of type 2 diabetes medication cost sharing on patient outcomes and health plan costs.
    Thornton Snider J; Seabury S; Lopez J; McKenzie S; Goldman DP
    Am J Manag Care; 2016 Jun; 22(6):433-40. PubMed ID: 27355811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.